CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Volume 15 Issue 1

How Are Emerging Biotechs Harnessing Strategic Partnerships to Strengthen Their Journey to Commercialisation?

Forecasted to reach $108 billion by 2023, the global pharmaceutical services outsourcing market is currently undergoing incredible levels of growth. Organisations...
Continue Reading →
Volume 15 Issue 1

Navigating the Data-driven Future of Life Sciences Regulatory Processes: Who Will Take the Lead?

Generis hosted a live video discussion with a panel of industry thought leaders from BioNTech, Bayer, Iperion – a Deloitte business, and Beczek. COM to discuss the c...
Continue Reading →
Volume 15 Issue 1

Data Transformation to Accelerate Time to Market and Address Product Shortages in Life Sciences Postpandemic

Frits Stulp of Iperion, a Deloitte business, predicts that a wave of data-driven transformation that began in 2022 will enhance insights and decision-making, allowin...
Continue Reading →
Volume 15 Issue 1

Revolutionising Life Sciences Research and Delivery with a New Approach to Modelling Complexity

In life sciences, the adoption of new standards such as SDTM and ADaM is proving critical for efficient and effective data management and sharing. SDTM provides a ne...
Continue Reading →
Volume 15 Issue 1

Local Lung Delivery for Small and Large Molecules Via Dry Powder Inhaler

Inhalation is a familiar route of delivery for many drugs designed to treat asthma and related conditions. Asthmatics routinely carry some form of metered dose inhal...
Continue Reading →
Volume 15 Issue 1

Connected Drug Delivery Device Development: Where Are We At?

The market for parenteral drug-device combination products has evolved rapidly over the last 15–20 years and is expected to grow at a CAGR of 24.3% in the next eight...
Continue Reading →
Volume 15 Issue 1

Fast-moving Pharma Organisations Prescribe GamifiedTraining to Keep Coaching and Management SkillsScalpel-sharp

In an industry where new technologies and techniques are advancing all the time, cutting-edge coaching training is key to helping people keep pace with change. Big p...
Continue Reading →
Volume 15 Issue 1

Current Trends in Pharma Production and Manufacturing

Through a series of exclusive interviews and a survey of industry insiders, Connect in Pharma identifies the top trends in pharmaceutical manufacturing for 2023. ...
Continue Reading →
Sponsored Articles

A More Connected Future for Pharma

In the lead-up to the inaugural launch of Connect In Pharma, co-founder Wilfried Phipps provides insight into what visitors can expect at this new annual event desig...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026